Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era
Authors
Keywords
-
Journal
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Volume 86, Issue 3, Pages 339-343
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-11-05
DOI
10.1097/qai.0000000000002556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy
- (2020) Jordan E Lake et al. CLINICAL INFECTIOUS DISEASES
- Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy
- (2019) Kassem Bourgi et al. CLINICAL INFECTIOUS DISEASES
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
- (2019) Maximilian Huhn et al. LANCET
- Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
- (2019) Willem D.F. Venter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients
- (2019) Sebastiano Rizzardo et al. AIDS
- Incidence and Risk Factors for Prediabetes and Diabetes Mellitus Among HIV-infected Adults on Antiretroviral Therapy
- (2018) Jobert Richie Nansseu et al. EPIDEMIOLOGY
- Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors
- (2018) David R Bakal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015
- (2018) Robin M. Nance et al. ANNALS OF INTERNAL MEDICINE
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2018) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Progressive increases in fat mass occur in adults living with HIV on antiretroviral therapy, but patterns differ by sex and anatomic depot
- (2018) Paula Debroy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality
- (2018) Shejil Kumar et al. Frontiers in Endocrinology
- Brief Report
- (2017) Jamison Norwood et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The triumph of HIV treatment: another new antiretroviral
- (2017) Marta Boffito et al. LANCET
- Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
- (2017) Paul E Sax et al. LANCET
- Long-term body composition changes in antiretroviral-treated HIV-infected individuals
- (2016) Philip M. Grant et al. AIDS
- Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada
- (2016) John R. Koethe et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Higher Time-Updated Body Mass Index
- (2016) John R. Koethe et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy
- (2016) Josep M. Llibre et al. PLoS One
- The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy
- (2015) John R. Koethe et al. AIDS
- Weight Change After Antiretroviral Therapy and Mortality
- (2015) B. Yuh et al. CLINICAL INFECTIOUS DISEASES
- Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
- (2013) Francois Raffi et al. LANCET
- Short Communication: From Wasting to Obesity: Initial Antiretroviral Therapy and Weight Gain in HIV-Infected Persons
- (2012) Wanda Lakey et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- HIV infection and obesity: where did all the wasting go?
- (2012) Tyler Tate et al. ANTIVIRAL THERAPY
- Raltegravir: The First HIV Type 1 Integrase Inhibitor
- (2009) Charles Hicks et al. CLINICAL INFECTIOUS DISEASES
- Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy
- (2008) HM Crane et al. HIV MEDICINE
- Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
- (2008) M. M Kitahata et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now